Syndrome News and Research

RSS
SARS-CoV-2 Delta variant transmitted by fully vaccinated individuals in Provincetown, Massachusetts

SARS-CoV-2 Delta variant transmitted by fully vaccinated individuals in Provincetown, Massachusetts

How COVID-19 affects household food security

How COVID-19 affects household food security

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

Rutgers study links genetic disorders to walking patterns

Rutgers study links genetic disorders to walking patterns

COVID lockdowns affect preschoolers' eating, activity and sleep routines, parents say

COVID lockdowns affect preschoolers' eating, activity and sleep routines, parents say

Compared to influenza, COVID-19 is more likely to cause venous thrombosis

Compared to influenza, COVID-19 is more likely to cause venous thrombosis

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

Immune evasion by SARS-CoV-2 facilitated by a mutational hotspot in the NTD

Immune evasion by SARS-CoV-2 facilitated by a mutational hotspot in the NTD

Does previous SARS-CoV-2 infection affect vaccine-induced immunity?

Does previous SARS-CoV-2 infection affect vaccine-induced immunity?

Mapping the molecular gene signatures of respiratory viruses, including SARS-CoV-2

Mapping the molecular gene signatures of respiratory viruses, including SARS-CoV-2

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

Gene therapy strategy against Angelman syndrome shows early promise

Gene therapy strategy against Angelman syndrome shows early promise

Chemical substance may specifically inhibit both SARS-CoV-2 proteases and human protease

Chemical substance may specifically inhibit both SARS-CoV-2 proteases and human protease

Mu and C.1.2 variant spike proteins partially resistant to neutralization by vaccine-elicited antibodies

Mu and C.1.2 variant spike proteins partially resistant to neutralization by vaccine-elicited antibodies

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

Using saliva to predict COVID-19 severity in children

Using saliva to predict COVID-19 severity in children

Immunogenicity and efficacy of adjuvanted SARS-CoV-2 beta variant subunit booster in rhesus macaques

Immunogenicity and efficacy of adjuvanted SARS-CoV-2 beta variant subunit booster in rhesus macaques

Replication of SARS-CoV-2 variants in different cell and organ models

Replication of SARS-CoV-2 variants in different cell and organ models

Development of a safe and effective COVID-19 nanoparticle vaccine

Development of a safe and effective COVID-19 nanoparticle vaccine